Cargando…
FcγRIIb-BCR coligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia
Autores principales: | Bosch, Rosa, Mora, Alba, Cuellar, Carolina, Ferrer, Gerardo, Gorlatov, Sergey, Nomdedéu, Josep, Montserrat, Emili, Sierra, Jorge, Rai, Kanti R., Chiorazzi, Nicholas, Moreno, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776347/ https://www.ncbi.nlm.nih.gov/pubmed/32336680 http://dx.doi.org/10.3324/haematol.2019.245795 |
Ejemplares similares
-
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016) -
The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019) -
Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018) -
FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021) -
Role of lipid nanodomains for inhibitory FcγRIIb function
por: Spiegel, Franziska, et al.
Publicado: (2023)